现代妇产科进展2024,Vol.33Issue(4):270-274,5.DOI:10.13283/j.cnki.xdfckjz.2024.04.031
IL-17B和STAT3在上皮性卵巢癌中的表达及临床意义
Expression and clinical significance of IL-17B and STAT3 in epithelial ovarian cancer
刘丽丽 1牛兆园 2亓晓莹 2付磊 2刘鸣2
作者信息
- 1. 青岛大学医学部,青岛 266071||青岛大学附属医院妇科,青岛 266003
- 2. 青岛大学附属医院妇科,青岛 266003
- 折叠
摘要
Abstract
Objective:To investigate the expression and clinical significance of inter-leukin(IL)-17B,cell signaling and transcriptional activator(STAT)3 protein in epithelial ovari-an cancer tissues.Methods:The expressions of IL-17B and STAT3 in 50 cases of epithelial o-varian cancer,28 cases of benign ovarian epithelial tumor and 18 cases of normal ovary tissues was detected by immunohistochemical staining.The relationship between IL-17B and STAT3 and the clinicopathological features of epithelial ovarian cancer was investigated.The prognosis was analyzed.Results:The expressions of IL-17B and STAT3 in epithelial ovarian cancer was related to FIGO stage,pathological type,and degree of tissue differentiation(P<0.05),but not with age and lymph node metastasis(P>0.05).The expressions of IL-17B and STAT3 in epi-thelial ovarian cancer was positively correlated(r=0.364).The IL-17B and STAT3 high-ex-pression group in epithelial ovarian cancer was closely related to the poor prognosis of patients,and the overall survival of patients with high IL-17B and STAT3 expression was significantly shortened(P<0.05).Conclusion:IL-17B and STAT3 may be involved in the occurrence and development of epithelial ovarian cancer,and are expected to be used as predictors of clinical prognosis of epithelial ovarian cancer.关键词
上皮性卵巢癌/白介素-17B/细胞信号和转录激活因子3/免疫组织化学Key words
Epithelial ovarian cancer/Interleukin-17B/Cell signaling and transcrip-tional activators 3/Immunohistochemistry分类
医药卫生引用本文复制引用
刘丽丽,牛兆园,亓晓莹,付磊,刘鸣..IL-17B和STAT3在上皮性卵巢癌中的表达及临床意义[J].现代妇产科进展,2024,33(4):270-274,5.